NCT06596382View on ClinicalTrials.gov

Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease

NACompletedINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Non-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Tocotrienol rich-vitamin E

Two dosage are available which are 100 mg for NAFLD patient with underlying metabolic syndrome meanwhile 50mg for NALFD patient without metabolic syndrome

DIETARY_SUPPLEMENT

Placebo

Replicate for tocotrienol rich-vitamin E without any active ingredients

Trial Locations (1)

56000

Hospital Canselor Tuanku Muhriz UKM, Cheras

All Listed Sponsors
lead

National University of Malaysia

OTHER

NCT06596382 - Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter